Roy Calne

8.2k total citations · 3 hit papers
119 papers, 5.9k citations indexed

About

Roy Calne is a scholar working on Surgery, Transplantation and Hepatology. According to data from OpenAlex, Roy Calne has authored 119 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 40 papers in Transplantation and 32 papers in Hepatology. Recurrent topics in Roy Calne's work include Organ Transplantation Techniques and Outcomes (38 papers), Renal Transplantation Outcomes and Treatments (34 papers) and Liver Disease and Transplantation (21 papers). Roy Calne is often cited by papers focused on Organ Transplantation Techniques and Outcomes (38 papers), Renal Transplantation Outcomes and Treatments (34 papers) and Liver Disease and Transplantation (21 papers). Roy Calne collaborates with scholars based in United Kingdom, Singapore and United States. Roy Calne's co-authors include Naoshi Kamada, Neville V. Jamieson, HUGH FF. S. DAVIES, Keith Rolles, Roger Williams, R J Polson, Peter J. Friend, David Evans, James Neuberger and Bernard Portmann and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Roy Calne

115 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

1999 700 citations Carl G. Groth, Lars Bäckman et al. Transplantation profile →
Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage.

1979 559 citations Roy Calne et al. profile →
ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT

1979 523 citations Roy Calne et al. Transplantation profile →

Peers

Countries citing papers authored by Roy Calne

Since Specialization

Citations

This map shows the geographic impact of Roy Calne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Calne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Calne more than expected).

Fields of papers citing papers by Roy Calne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Calne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Calne. The network helps show where Roy Calne may publish in the future.

Co-authorship network of co-authors of Roy Calne

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Calne. A scholar is included among the top collaborators of Roy Calne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Calne. Roy Calne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Some observations on prope tolerance 2011 ·Current Opinion in Organ Transplantation ·Roy Calne, Christopher J.E. Watson	16
2	Alemtuzumab (CAMPATH-1H) for the Treatment of Acute Rejection in Kidney Transplant Recipients: Long-Term Follow-Up 2009 ·Transplantation ·Menna R. Clatworthy, Peter J. Friend, Roy Calne, P Rebello, G Hale, Herman Waldmann, Christopher J.E. Watson	40
3	Essay: History of transplantation 2006 ·The Lancet ·Roy Calne	4
4	Possible Advantages of Stem Cell Transfusion into the Peripheral Circulation, As Opposed to Localized Transplantation In Situ 2005 ·Stem Cells and Development ·Boon Chin Heng, Ian McNiece, (unknown), Roy Calne, Tong Cao	2
5	Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1 2005 ·Transplantation ·Anantharaman Vathsala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Machin, G.S.C. Chiang, Romina A. Danguilan, Roy Calne	90
6	Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation―Efficacy and Safety at Five Years 2005 ·American Journal of Transplantation ·Christopher J.E. Watson, J. Andrew Bradley, Peter J. Friend, John Firth, Craig J. Taylor, John R. Bradley, Kenneth G. C. Smith, S Thiru, Neville V. Jamieson, G Hale, Herman Waldmann, Roy Calne	167
7	The use of alemtuzumab (Campath 1H) in organ transplant recipients 2005 ·Current Opinion in Organ Transplantation ·Roy Calne	1
8	Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys1,2 2002 ·Transplantation ·Margreet Jonker, Jan Ringers, Miriam A. Ossevoort, (unknown), (unknown), Krista G. Haanstra, Jacqueline Wubben, Eva Kühn, Peter J. Friend, Roy Calne	14
9	SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION breakdown → 1999 ·Transplantation ·Carl G. Groth, Lars Bäckman, (unknown), Roy Calne, Henri Kreis, Philippe Lang, Jean-Louis Touraine, Kerstin Claesson, Josep M. Campistol, D. Durand, Lars Wramner, C Brattström, Bernard Charpentier	700
10	POTENTIAL FOR IMPROVED THERAPEUTIC INDEX OF FK506 IN LIPOSOMAL FORMULATION DEMONSTRATED IN A MOUSE CARDIAC ALLOGRAFT MODEL1,2 1999 ·Transplantation ·Susan Moffatt, Vivian C. McAlister, Roy Calne, Su Metcalfe	15
11	Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens 1997 ·Transplant International ·P. Neuhaus, Jan M. Langrehr, Roger Williams, Roy Calne, R. Pichlmayr, Paul McMaster	33
12	RADIONUCLIDE STUDIES IN INTESTINAL TRANSPLANTATION 1996 ·Transplantation ·Christopher J.E. Watson, (unknown), G. Neale, Neville V. Jamieson, Peter J. Friend, Roy Calne	14
13	The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats 1995 ·Nature Medicine ·(unknown), HUGH FF. S. DAVIES, Roy Calne	107
14	ETHNIC VARIATIONS IN PATIENT AND GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION 1993 ·Transplantation ·John Devlin, John G. O’Grady, K. C. Tan, Roy Calne, Roger Williams	46
15	THE PLATELET-ACTIVATING FACTOR ANTAGONIST WEB 2170 ITS BENEFICIAL EFFECT ON DOG RENAL ALLOGRAFT SURVIVAL 1993 ·Transplantation ·Christopher J.E. Watson, Roger Luddington, (unknown), Roy Calne, Susan M. Metcalfe	1
16	Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis 1989 ·Gastroenterology ·R J Polson, Bernard Portmann, James Neuberger, Roy Calne, Roger Williams	30
17	THE EFFECT OF LIVER TRANSPLANTATION IN A 13-YEAR-OLD BOY WITH ERYTHROPOIETIC PROTOPORPHYRIA 1988 ·Transplantation ·R J Polson, Chang Kee Lim, Keith Rolles, Roy Calne, Roger Williams	47
18	Transplantation immunology : clinical and experimental 1984 ·Oxford University Press eBooks ·Roy Calne	15
19	A Simplified Technique for Orthotopic Liver Transplantation in the Rat Using a Cuff Technique for Portal Vein and Infrahepatic Vena Cava Anastomoses 1981 ·European Surgical Research ·J Limmer, Roy Calne	6
20	Orthotopic Rat Liver Transplantation Using Different Combinations of Four Inbred Strains 1980 ·European Surgical Research ·J Limmer, B. M. Herbertson, Roy Calne	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact